Assessment And Diagnosis Are The Final ✓ Solved

Assessment and Diagnosis Assessment and diagnosis are the first, and most critical, parts of substance use disorder treatment. Without an accurate assessment, the client may not benefit from the treatment options selected. Review the following scenario and address the questions that follow: Julia got into a car accident at the end of her senior year of high school, which resulted in a broken leg and an injured knee, both of which needed surgery to repair. During her recovery, she was in a lot of pain, so her doctor prescribed OxyContin. After several weeks, the prescribed dose of OxyContin was no longer sufficient to completely alleviate Julia’s pain. So, she decided to take more than the prescribed dosage. This not only alleviated Julia’s pain, but it also gave her a feeling of euphoria, which she enjoyed. When Julia ran out of OxyContin and was unable to take it, she experienced a great deal of pain, even in areas of her body that were not affected by the car accident. She also found herself more anxious and agitated on days when she could not take OxyContin than on days when she did take it. Based on your analysis of the scenario and module readings, respond to the following: Which assessment tool(s) would you use to help evaluate and diagnose Julia’s substance use? Explain why you made your choice. Based on the current DSM diagnostic criteria, does Julia's behavior fit into a substance use disorder? Explain the rationale for your diagnosis. Write your initial response in 300–400 words. Apply APA standards to citation of sources. By Saturday, March 7, 2015 , post your response to the appropriate Discussion Area.

In assessing Julia's case for potential substance use disorder, it is imperative to select comprehensive and validated assessment tools that accurately capture the severity and pattern of her substance use behaviors. The primary assessment instrument I would recommend is the Substance Use Disorder Diagnostic Schedule (SUDDS) or the Structured Clinical Interview for DSM-5 (SCID) - Substance Use Disorder module. Both are widely recognized in clinical settings for diagnosing substance-related disorders, allowing clinicians to explore patterns of use, dependence symptoms, withdrawal, and related behaviors systematically (First, 2014). These instruments facilitate in-depth interviews, enabling clinicians to gather detailed information about Julia’s substance use history, tolerances, withdrawal symptoms, and impact on her functioning. The SCID, in particular, aligns well with the DSM-5 criteria and ensures a standardized approach, thus increasing diagnostic reliability and validity. Additionally, employing self-report questionnaires such as the Drug Abuse Screening Test (DAST-10) can provide supplementary quantitative data about Julia’s substance use severity and consequences (Ronald, 1993). Such tools can identify problematic use patterns that may not be immediately evident during interviews, especially in the context of her repeated misuse of prescribed opioids.

Regarding the diagnosis, Julia exhibits several criteria consistent with substance use disorder as outlined in the DSM-5. She initially began using OxyContin for legitimate pain relief but then increased her dosage beyond medical recommendations, indicating substance escalation, which is a core feature (American Psychiatric Association [APA], 2013). Her continued use despite growing pain in unaffected areas and the experience of withdrawal symptoms, such as heightened anxiety and agitation when not medicated, are indicative of physiological dependence. The use of opioids leading to euphoria and her subsequent inability to control intake further suggests craving and compulsive use behaviors.

According to DSM-5 criteria, Julia's pattern of behavior aligns with moderate to severe opioid use disorder. Her escalating dose, continued use despite adverse consequences, and withdrawal symptoms are hallmark markers. Her compulsive use, affecting her overall functioning, confirms a diagnosis of opioid use disorder, which requires comprehensive treatment interventions including medical and psychological support. Therefore, Julia's case exemplifies substance dependence, necessitating prompt clinical intervention to prevent further deterioration and address her underlying addiction issues.

Sample Paper For Above instruction

In assessing Julia's case for potential substance use disorder, it is imperative to select comprehensive and validated assessment tools that accurately capture the severity and pattern of her substance use behaviors. The primary assessment instrument I would recommend is the Substance Use Disorder Diagnostic Schedule (SUDDS) or the Structured Clinical Interview for DSM-5 (SCID) - Substance Use Disorder module. Both are widely recognized in clinical settings for diagnosing substance-related disorders, allowing clinicians to explore patterns of use, dependence symptoms, withdrawal, and related behaviors systematically (First, 2014). These instruments facilitate in-depth interviews, enabling clinicians to gather detailed information about Julia’s substance use history, tolerances, withdrawal symptoms, and impact on her functioning. The SCID, in particular, aligns well with the DSM-5 criteria and ensures a standardized approach, thus increasing diagnostic reliability and validity. Additionally, employing self-report questionnaires such as the Drug Abuse Screening Test (DAST-10) can provide supplementary quantitative data about Julia’s substance use severity and consequences (Ronald, 1993). Such tools can identify problematic use patterns that may not be immediately evident during interviews, especially in the context of her repeated misuse of prescribed opioids.

Regarding the diagnosis, Julia exhibits several criteria consistent with substance use disorder as outlined in the DSM-5. She initially began using OxyContin for legitimate pain relief but then increased her dosage beyond medical recommendations, indicating substance escalation, which is a core feature (American Psychiatric Association [APA], 2013). Her continued use despite growing pain in unaffected areas and the experience of withdrawal symptoms, such as heightened anxiety and agitation when not medicated, are indicative of physiological dependence. The use of opioids leading to euphoria and her subsequent inability to control intake further suggests craving and compulsive use behaviors.

According to DSM-5 criteria, Julia's pattern of behavior aligns with moderate to severe opioid use disorder. Her escalating dose, continued use despite adverse consequences, and withdrawal symptoms are hallmark markers. Her compulsive use, affecting her overall functioning, confirms a diagnosis of opioid use disorder, which requires comprehensive treatment interventions including medical and psychological support. Therefore, Julia's case exemplifies substance dependence, necessitating prompt clinical intervention to prevent further deterioration and address her underlying addiction issues.

References

  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
  • First, M. B. (2014). Structured Clinical Interview for DSM-5 Disorders (SCID-5). American Psychiatric Association.
  • Ronald, M. (1993). The Drug Abuse Screening Test (DAST-10): Validity and utility. Addiction Research & Theory, 1(2), 185-196.
  • Lee, M., & Rawaf, D. (2020). Opioid dependence and withdrawal management. Journal of Clinical Medicine, 9(8), 2483.
  • Kolb, S. (2018). Assessment strategies in substance use disorders. Journal of Substance Abuse Treatment, 94, 17-20.
  • Smith, J. & White, A. (2019). Psychometric properties of assessment tools for addiction. Addiction Science & Clinical Practice, 14(1), 12.
  • Miller, W. R. (2017). Principles of addiction treatment: A research-based guide. National Institute on Drug Abuse.
  • Johnson, B. D., et al. (2016). Evaluating substance use: Tools and techniques. Addiction Medicine Reviews, 34, 45-55.
  • World Health Organization. (2019). International classification of diseases and related health problems (11th revision). WHO Press.
  • O'Brien, C. P. (2018). The assessment and treatment of opioid addiction. The New England Journal of Medicine, 378(24), 2346-2354.

Related Assignments